Clinical Trial

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

Study acronym: A-TEAM
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively. The investigators call our approach "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring). The aims of this application are to determine the acceptability and feasibility of real-time adherence monitoring in support persons and case managers of African American Men who have sex with Men and to test this approach for these men in a 6-month randomized controlled trial among 54 of these men living with HIV and measure ART adherence and viral suppression (the primary outcome).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-12.
Status change: Not Yet Recruiting → Recruiting 2024-11-18
Trial Details
NCT Number NCT06550804
Lead Sponsor University of Illinois at Chicago
Collaborators: Massachusetts General Hospital
Conditions HIV Infections, Adherence, Medication
Enrollment 126 participants
Start Date 2024-10-01
Primary Completion 2026-02 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-11-21